Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05170854 · ClinicalTrials.gov registry record
The Impact of Liver Cirrhosis on Outcomes in Trauma Patients
A clinical trial of Cirrhosis, sponsored by Methodist Health System.
- Active
- Registry status
- 4,774,035
- Enrollment target
- 1
- Study location
NCT05170854: Active study of Cirrhosis, sponsored by Methodist Health System.
NCT05170854 is a study of Cirrhosis that is active but no longer recruiting, run by Methodist Health System. The registered enrollment target is 4,774,035 participants, above the 333-participant average among 53 other Cirrhosis trials with a reported enrollment target (1433544% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05170854, a study of Cirrhosis, is active but no longer recruiting, sponsored by Methodist Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 4,774,035 participants
- Enrollment target
- 1
- Study location
Study Summary
Given that there are only a few studies on the effects of cirrhosis on trauma patients and none have addressed the impact cirrhosis has on the incidence of infections, it is important that we study this to determine the mortality in cirrhotic trauma patients and ascertain the incidence of infectious complications in these patients. We hypothesize that trauma patients with cirrhosis will have higher rates of mortality and infectious complications.
Primary Outcome
Patient death
Conditions Studied
Study Locations (1)
Texas
- Methodist Health System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,774,035 participants |
| Start Date | 2018-10-16 |
| Est. Completion | 2026-08 |
What the registry record for NCT05170854 still lists
NCT05170854 is an observational study that tracks outcomes without assigning an intervention. Its 4,774,035 participants enrollment target places it among the larger protocols in the corpus, above the 333-participant average among 53 other Cirrhosis trials with a reported enrollment target (1433544% higher).
The record links to 1 condition, with Cirrhosis appearing as the primary indexed condition, and to 0 interventions.
NCT05170854 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05170854 about?
NCT05170854 is a clinical study titled "The Impact of Liver Cirrhosis on Outcomes in Trauma Patients". Given that there are only a few studies on the effects of cirrhosis on trauma patients and none have addressed the impact cirrhosis has on the incidence of infections, it is important that we study this to determine the mortality in cirrhotic trauma patients and ascertain the incidence of infectious...
What is the current status of trial NCT05170854?
This trial is currently active not recruiting. The enrollment target is 4,774,035 participants. The study started on 2018-10-16. Estimated completion is 2026-08.
What conditions does trial NCT05170854 study?
This clinical trial studies the following conditions: Cirrhosis.
Who is sponsoring clinical trial NCT05170854?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05170854 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05170854's enrollment target sits among peer trials
4,774,035 1st of 53 higher than 53 of 53 other Cirrhosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cirrhosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanisms of Malnutrition in Cirrhosis With Portosystemic Shunting
RECRUITING
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
RECRUITING · Phase 2
-
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
RECRUITING · Phase 3
-
Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02693223 · 3,892,063 participants
Get With the Guidelines-Stroke Registry
- NCT06803498 · 3,000,000 participants
Delivery Room Intervention and Evaluation Network
- NCT03813862 · 2,000,000 participants
Observational Pharmaco-Epidemiology Research & Analysis
- NCT06057181 · 2,000,000 participants
Helix Research Network
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI